These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 25895659

  • 1. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
    Müller M, Jäkel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM.
    Mol Neurobiol; 2016 Jul; 53(5):2894-2899. PubMed ID: 25895659
    [Abstract] [Full Text] [Related]

  • 2. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
    Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T.
    J Alzheimers Dis; 2014 Jul; 39(2):253-9. PubMed ID: 24157723
    [Abstract] [Full Text] [Related]

  • 3. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A, Molinuevo JL, Altirriba J, Sánchez-Valle R, Alcolea D, Fortea J, Rami L, Balasa M, Muñoz-García C, Ezquerra M, Fernández-Santiago R, Lleó A, Lladó A, Antonell A.
    Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
    [Abstract] [Full Text] [Related]

  • 4. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M, Kuiperij HB, Claassen JA, Küsters B, Verbeek MM.
    Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017 Jan; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 6. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    Lusardi TA, Phillips JI, Wiedrick JT, Harrington CA, Lind B, Lapidus JA, Quinn JF, Saugstad JA.
    J Alzheimers Dis; 2017 Jan; 55(3):1223-1233. PubMed ID: 27814298
    [Abstract] [Full Text] [Related]

  • 7. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
    Galimberti D, Villa C, Fenoglio C, Serpente M, Ghezzi L, Cioffi SM, Arighi A, Fumagalli G, Scarpini E.
    J Alzheimers Dis; 2014 Jan; 42(4):1261-7. PubMed ID: 25024331
    [Abstract] [Full Text] [Related]

  • 8. Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.
    Müller M, Kuiperij HB, Versleijen AA, Chiasserini D, Farotti L, Baschieri F, Parnetti L, Struyfs H, De Roeck N, Luyckx J, Engelborghs S, Claassen JA, Verbeek MM.
    J Alzheimers Dis; 2016 Apr 16; 52(4):1321-33. PubMed ID: 27104900
    [Abstract] [Full Text] [Related]

  • 9. Circulating miR-125b as a biomarker of Alzheimer's disease.
    Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, Wang YL, Sun L, Jiang T, Tan L.
    J Neurol Sci; 2014 Jan 15; 336(1-2):52-6. PubMed ID: 24139697
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
    McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA, Boxer AL, Karydas A, Miller B, Robertson J, Tartaglia MC.
    Mol Neurobiol; 2018 Dec 15; 55(12):8826-8841. PubMed ID: 29603092
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H.
    PLoS One; 2015 Dec 15; 10(5):e0126423. PubMed ID: 25992776
    [Abstract] [Full Text] [Related]

  • 12. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid.
    Wiedrick JT, Phillips JI, Lusardi TA, McFarland TJ, Lind B, Sandau US, Harrington CA, Lapidus JA, Galasko DR, Quinn JF, Saugstad JA.
    J Alzheimers Dis; 2019 Dec 15; 67(3):875-891. PubMed ID: 30689565
    [Abstract] [Full Text] [Related]

  • 13. Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    van Harten AC, Mulders J, Scheltens P, van der Flier WM, Oudejans CB.
    J Alzheimers Dis; 2015 Dec 15; 47(1):243-52. PubMed ID: 26402772
    [Abstract] [Full Text] [Related]

  • 14. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease.
    Sala Frigerio C, Lau P, Salta E, Tournoy J, Bossers K, Vandenberghe R, Wallin A, Bjerke M, Zetterberg H, Blennow K, De Strooper B.
    Neurology; 2013 Dec 10; 81(24):2103-6. PubMed ID: 24212398
    [Abstract] [Full Text] [Related]

  • 15. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S, Reddy PH.
    Biochim Biophys Acta; 2016 Sep 10; 1862(9):1617-27. PubMed ID: 27264337
    [Abstract] [Full Text] [Related]

  • 16. Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls.
    Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML, Volk AE, Diehl-Schmid J, Prudlo J, Danek A, Landwehrmeyer B, Lauer M, Otto M, Jahn H, FTLDc study group.
    PLoS One; 2018 Sep 10; 13(5):e0197329. PubMed ID: 29746584
    [Abstract] [Full Text] [Related]

  • 17. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
    Kim SH, Choi KY, Park Y, McLean C, Park J, Lee JH, Lee KH, Kim BC, Huh YH, Lee KH, Song WK.
    Cells; 2021 Oct 09; 10(10):. PubMed ID: 34685681
    [Abstract] [Full Text] [Related]

  • 18. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
    Yılmaz ŞG, Erdal ME, Özge AA, Sungur MA.
    OMICS; 2016 Aug 09; 20(8):456-61. PubMed ID: 27501295
    [Abstract] [Full Text] [Related]

  • 19. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 20. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.
    Mol Neurobiol; 2017 Sep 10; 54(7):5550-5562. PubMed ID: 27631879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.